BRIVANIB (B) IN ADVANCED OVARIAN CANCER (OC): SUBSET RESULTS OF A PHASE 2 RANDOMIZED DISCONTINUATION TRIAL (RDT)

被引：0

作者：

Kaye, S. B. ^{[1
,2
]}

Siu, L. L. ^{[3
]}

Jassem, J. ^{[4
]}

Medioni, J. ^{[5
]}

Soetekouw, P. M. M. B. ^{[6
]}

Slater, S. ^{[7
]}

Rudin, C. M. ^{[8
]}

Schwartz, G. K. ^{[9
]}

De Jonge, M. ^{[10
]}

O'Dwyer, P. ^{[11
]}

Baudelet, C. ^{[12
]}

Chen, A. ^{[13
]}

Ratain, M. J. ^{[14
]}

机构：

[1] Royal Marsden Hosp, Sutton, Surrey, England

[2] Inst Canc Res, Sutton, Surrey, England

[3] Princess Margaret Hosp, Dept Med Oncol, Toronto, ON M4X 1K9, Canada

[4] Med Univ Gdansk, Gdansk, Poland

[5] Hop Europeen Georges Pompidou, Dept Med Oncol, Paris, France

[6] Maastricht Univ, Med Ctr, Div Med Oncol, Maastricht, Netherlands

[7] Beatson W Scotland Canc Ctr, Dept Med Oncol, Glasgow, Lanark, Scotland

[8] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[9] Mem Sloan Kettering Canc Ctr, Melanoma & Sarcoma Serv, New York, NY 10021 USA

[10] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands

[11] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[12] Brstol Myers Squibb, Res & Dev, Braine Lalleud, Belgium

[13] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA

[14] Univ Chicago, Dept Med, Chicago, IL 60637 USA

来源：

ANNALS OF ONCOLOGY | 2012年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：319 / 319

页数：1

共 50 条

[31] Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer [J].

Aziz, Z ;

Zahid, M ;

Ahmed, ZUD ;

Arshad, T .

AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (03) :403-409

[32] A randomized phase III trial of concurrent chemoradiation in locally advanced cervical cancer: preliminary results [J].

Veerasarn, V. ;

Lorvidhaya, V. ;

Suntornpong, N. ;

Sukthomya, V. ;

Sangruchi, S. ;

Chitapanarux, I. ;

Lertsanguansinchai, P. ;

Khorprasert, C. ;

Sookpreedee, L. ;

Udompunturak, S. .

EJC SUPPLEMENTS, 2005, 3 (02) :260-260

[33] A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: Preliminary results [J].

Veerasarn, Vutisiri ;

Lorvidhaya, Vicharn ;

Kamnerdsupaphon, Pimkhuan ;

Suntornpong, Nan ;

Sangruchi, Supatra ;

Lertsanguansinchai, Prasert ;

Khorprasert, Chonlakiet ;

Sookpreedee, Lak ;

Udompunturak, Suthipol .

GYNECOLOGIC ONCOLOGY, 2007, 104 (01) :15-23

[34] PHASE-2 TRIAL OF CYTEMBENA IN PATIENTS WITH ADVANCED OVARIAN AND BREAST-CANCER [J].

FALKSON, HC ;

FALKSON, G .

CANCER TREATMENT REPORTS, 1976, 60 (11) :1655-1658

[35] RANDOMIZED TRIAL IN ADVANCED OVARIAN-CANCER COMPARING CISPLATIN AND CARBOPLATIN [J].

MANGIONI, C ;

BOLIS, G ;

PECORELLI, S ;

BRAGMAN, K ;

EPIS, A ;

FAVALLI, G ;

GAMBINO, A ;

LANDONI, F ;

PRESTI, M ;

TORRI, W ;

VASSENA, L ;

ZANABONI, F ;

MARSONI, S .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (19) :1464-1471

[36] Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer [J].

Garcia Garcia, Yolanda ;

de Juan Ferre, Ana ;

Mendiola, Cesar ;

Barretina-Ginesta, Maria-Pilar ;

Gaba Garcia, Lydia ;

Santaballa Bertran, Ana ;

Bover Barcelo, Isabel ;

Gil-Martin, Marta ;

Manzano, Aranzazu ;

Rubio Perez, Maria Jesus ;

Romeo Marin, Margarita ;

Arqueros Nunez, Cristina ;

Garcia-Martinez, Elena ;

Gonzalez Martin, Antonio .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (06) :1050-1056

[37] RESULTS OF PHASE II TRIAL OF DENDRITIC CELL BASED VACCINE THERAPY IN ADVANCED EPITHELIAL OVARIAN CANCER [J].

Tsip, N. ;

Khranovska, N. ;

Vorobyova, L. ;

Skachkova, O. ;

Svyntsytsky, V. ;

Svergun, N. ;

Gorbach, O. .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) :85-85

[38] Phase I study of intraperitoneal (IP) denileukin diftitox in patients with advanced ovarian cancer (OC) [J].

Salazar, L. G. ;

Swensen, R. ;

Markle, V. ;

Coveler, A. ;

Royer, B. ;

Dang, Y. ;

Slota, M. ;

Childs, J. ;

Wallace, D. ;

Disis, M. L. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[39] Carboplatin and Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer: Preliminary Activity Results of the MITO-2 Phase III Trial [J].

Pignata, S. ;

Scambia, G. ;

Savarese, A. ;

Breda, E. ;

Sorio, R. ;

Pisano, C. ;

Lorusso, D. ;

Cognetti, F. ;

Lombardi, A. Vernaglia ;

Gebbia, V. ;

Scollo, P. ;

Morabito, A. ;

Signoriello, G. ;

Perrone, F. .

ONCOLOGY, 2009, 76 (01) :49-54

[40] Final results of ARIEL2 (Part 1): A phase 2 trial to prospectively identify ovarian cancer (OC) responders to rucaparib using tumor genetic analysis [J].

Kristeleit, R. ;

Swisher, E. ;

Oza, A. ;

Coleman, R. L. ;

Scott, C. ;

Konecny, G. ;

Tinker, A. ;

O'Malley, D. M. ;

Brenton, J. ;

Bell-McGuinn, K. ;

Oaknin, A. ;

Leary, A. ;

Lin, K. K. ;

Raponi, M. ;

Giordano, H. ;

Maloney, L. ;

Goble, S. ;

Yelensky, R. ;

McNeish, I. .

EUROPEAN JOURNAL OF CANCER, 2015, 51 :S531-S531

← 1 2 3 4 5 →